Home Ingredients OnoSweet® (Monk Fruit + Allulose Sweetener)
Metabolic Health

OnoSweet® (Monk Fruit + Allulose Sweetener)

Siraitia grosvenorii
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

OnoSweet® (Compound Solutions) is a patented natural zero-calorie sweetener system combining monk fruit extract (luo han guo, mogrosides) with allulose — providing a clean, non-glycemic sweetening solution with superior taste profile compared to either ingredient alone. Monk fruit mogrosides are 150–300x sweeter than sucrose with zero calories; allulose provides 70% of sucrose sweetness with near-zero caloric impact (0.4 kcal/g vs. 4 kcal/g for sucrose) and FDA GRAS status. The combination masks each other's aftertaste weaknesses for a clean, sugar-like taste experience.

Studied Dose Formulation ingredient — use per product recipe to achieve target sweetness; no clinical supplementation dose as consumed in trace amounts as sweetener
Active Compound Mogrosides V (monk fruit / Siraitia grosvenorii) + allulose (D-psicose) — OnoSweet® by Compound Solutions; zero-calorie natural sweetener system

Benefits

Zero-glycemic natural sweetening

OnoSweet® provides sweetness without glucose or insulin response — monk fruit mogrosides are not absorbed or metabolized by the body and pass through unchanged, while allulose is absorbed but not metabolized (excreted in urine). Both components produce no meaningful glycemic or insulinemic response, making OnoSweet® suitable for diabetics, low-carbohydrate dieters, and anyone managing blood sugar.

Supported by Trial 1

Clean taste without artificial sweetener aftertaste

The combination of monk fruit and allulose achieves a taste profile closer to sucrose than either alone. Monk fruit's lingering sweet aftertaste is balanced by allulose's sucrose-like mouthfeel and temporal sweetness profile. This superior taste performance vs. single sweeteners (stevia, erythritol, sucralose) makes OnoSweet® ideal for clean-label products requiring natural, calorie-free sweetening.

Supported by Trial 1

Antioxidant and metabolic health properties of mogrosides

Monk fruit mogrosides — beyond their sweetening role — demonstrate antioxidant, anti-inflammatory, and antidiabetic properties in preclinical studies. Mogroside V inhibits advanced glycation end-product (AGE) formation, reduces oxidative stress markers, and shows anti-tumor activity in cell studies. Allulose improves insulin sensitivity and promotes fat oxidation in clinical studies at higher (food-level) intake.

Supported by Trial 1

Mechanism of action

1

Non-metabolizable sweetness and gut microbiome prebiotic effects

Monk fruit mogrosides bind sweet taste receptors (T1R2/T1R3 heterodimers) without enzymatic digestion or intestinal absorption — providing sweetness signal without caloric contribution. Allulose undergoes intestinal absorption but is transported without cellular metabolism and excreted renally. At higher intakes, allulose selectively modulates gut microbiome composition (increasing Akkermansia muciniphila) with potential metabolic benefits beyond its sweetener role.

Clinical trials

1
Allulose for Glycemic Response — Clinical Evidence

Multiple clinical studies and pooled analyses examining allulose effects on glycemic response, insulin sensitivity, and body composition. (; or related allulose pooled analyses)

Pooled across allulose clinical trials.

Allulose at sweetener replacement doses produced no meaningful glycemic or insulinemic response vs sucrose controls. Modest benefits on postprandial glucose when added to carbohydrate meals. Generally well-tolerated; GI symptoms (gas, diarrhea) at high doses (>0.4 g/kg). FDA recognizes allulose as an 'allowable' sweetener; it's exempt from added sugars labeling per 2019 FDA guidance.

Side effects and drug interactions

Common Potential side effects

GI effects (bloating, loose stools) at high allulose doses (>30g/day) — well below sweetener use levels
Monk fruit: no adverse effects documented; GRAS status
Rare allergy to Cucurbitaceae family (gourd family) — monk fruit is related; discontinue if reaction

Important Drug interactions

No significant drug interactions at sweetener use levels
Allulose at high doses may modestly lower blood glucose — relevant if on insulin or hypoglycemics

More Metabolic Health Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Muscle & Recovery
Magnesium
Magnesium is the fourth most abundant mineral in the body and a cofactor for over 300 enzy…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…

Explore Other Ingredients

Cognitive
Holy Basil (Tulsi)
Holy basil (tulsi) is a revered adaptogenic herb in Ayurvedic tradition, used to help the…
Energy
SalidroPure™ (Pure Salidroside)
SalidroPure™ is NNB Nutrition's precision-fermented pure salidroside — the primary bioacti…
Cognitive
Suntheanine®
Suntheanine® is a patented, 100% pure L-isomer theanine produced via an enzymatic process…

Frequently asked questions about OnoSweet® (Monk Fruit + Allulose Sweetener)

What is OnoSweet?

OnoSweet® (Compound Solutions) is a patented natural zero-calorie sweetener system combining monk fruit extract (luo han guo, mogrosides) with allulose — providing a clean, non-glycemic sweetening solution with superior taste profile compared to either ingredient alone.

What is OnoSweet used for?

OnoSweet is researched primarily for Metabolic Health. OnoSweet® provides sweetness without glucose or insulin response — monk fruit mogrosides are not absorbed or metabolized by the body and pass through unchanged, while allulose is absorbed but not metabolized (excreted in urine).

What is the recommended dosage of OnoSweet?

The clinically studied dose is Formulation ingredient — use per product recipe to achieve target sweetness; no clinical supplementation dose as consumed in trace amounts as sweetener Always follow the product label and check with a healthcare provider for personal advice.

Is OnoSweet safe, and does it have side effects?

For most healthy adults, OnoSweet is well tolerated at studied doses. Reported effects can include: GI effects (bloating, loose stools) at high allulose doses (>30g/day) — well below sweetener use levels Monk fruit: no adverse effects documented; GRAS status It may also interact with some medications. OnoSweet is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does OnoSweet interact with any medications?

Possible interactions include: No significant drug interactions at sweetener use levels Allulose at high doses may modestly lower blood glucose — relevant if on insulin or hypoglycemics If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for OnoSweet?

NutraSmarts rates the evidence for OnoSweet as Moderate (3 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kaim U, Labus K Monk Fruit Extract and Sustainable Health: A PRISMA-Guided Systematic Review of Randomized Controlled Trials. Nutrients. 2025;17(9):1433. doi: 10.3390/nu17091433.PubMedUsed to support: PRISMA-guided systematic review of RCTs on monk fruit extract summarizing evidence for zero-glycemic sweetening, antioxidant properties, and metabolic health effects, directly supporting OnoSweet®'s monk fruit component claims.
  2. Tani Y, Tokuda M, Nishimoto N, Yokoi H, Izumori K Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis. PLoS One. 2023;18(4):e0281150. doi: 10.1371/journal.pone.0281150.PubMedUsed to support: Systematic review and meta-analysis confirming allulose (the second component of OnoSweet®) attenuates postprandial blood glucose in healthy humans, supporting the zero-glycemic and metabolic health claims of the combined OnoSweet® blend.
  3. Teysseire F, Bordier V, Budzinska A, Van Oudenhove L, Weltens N, Beglinger C, Wölnerhanssen BK, Meyer-Gerspach AC Metabolic Effects and Safety Aspects of Acute D-allulose and Erythritol Administration in Healthy Subjects. Nutrients. 2023;15(2):458. doi: 10.3390/nu15020458.PubMedUsed to support: Acute crossover study in healthy adults showing D-allulose (allulose, the second component of OnoSweet®) improves metabolic parameters with favorable safety profile, supporting the clean-taste and metabolic health claims of OnoSweet®.